Bradycardia
Medically Reviewed by Dr. M. Salar Raza | Official SCFHS 2026 Blueprint
Clinical Pathway
Bradycardia is a medical condition characterized by a slower than normal heart rate, typically defined as fewer than 60 beats per minute (bpm) in adults. While sometimes physiological and benign, it can also indicate underlying cardiovascular or systemic issues that impair the heart's ability to effectively pump blood. Treatment for bradycardia depends on its underlying cause, severity, and the presence of symptoms. Asymptomatic bradycardia, especially in athletes, often requires no intervention. Symptomatic bradycardia may necessitate discontinuing or adjusting causative medications, treating underlying conditions, or in severe cases, implanting a permanent pacemaker to regulate heart rhythm. Acute, unstable bradycardia may require intravenous atropine or temporary pacing. Clinical manifestations range from asymptomatic presentation to severe symptoms depending on the degree of bradycardia and the patient's cardiovascular reserve. Common symptoms include fatigue, dizziness, lightheadedness, syncope (fainting), shortness of breath, and chest pain. In critical cases, it can lead to confusion, hypotension, and signs of organ hypoperfusion.
Clinical Reasoning
Bradycardia arises from dysfunction within the heart's electrical conduction system, most commonly involving a slow rate of impulse generation by the sinoatrial (SA) node or impaired transmission through the atrioventricular (AV) node. This can be due to structural heart disease, medication effects, electrolyte imbalances, or increased vagal tone, leading to a reduced ventricular contraction rate and potentially compromised cardiac output. The prognosis for bradycardia is highly variable and depends significantly on its underlying etiology, severity, and the patient's overall health status. Many individuals with physiological or mild, asymptomatic bradycardia have an excellent long-term prognosis. Patients requiring a permanent pacemaker generally experience improved symptoms and a good quality of life, though the prognosis is also influenced by any underlying structural heart disease. Aging (degenerative changes in the conduction system),Heart disease (e.g., coronary artery disease, prior myocardial infarction, cardiomyopathy),Medications (e.g., beta-blockers, calcium channel blockers, digoxin, antiarrhythmics),Hypothyroidism,Electrolyte imbalances (e.g., hyperkalemia),Sick sinus syndrome or heart block
Sample MCQ
A 70-year-old man presents with progressive dyspnea, fatigue, and recurrent episodes of presyncope. Physical examination reveals a variable intensity of the first heart sound (S1) and prominent jugular venous pulse (JVP) with "cannon a" waves. Which of the following is the definitive treatment?
- AImplantable cardioverter-defibrillator
- BPermanent pacemaker
- CRadiofrequency catheter ablation
- DOral metoprolol
Correct Answer: Permanent pacemaker
### TLDR The patient's symptoms and physical findings, including variable S1 and "cannon a" waves, are highly indicative of complete (third-degree) atrioventricular block. The definitive treatment for symptomatic complete heart block is the implantation of a **permanent pacemaker**. ### Comparison Table | Option | Mechanism | Clinical Nuance | Key Distinction | | :------------------------------ | :-------------------------------- | :----------------------------- | :---------------------------------- | | Implantable cardioverter-defibrillator | Detects and shocks tachyarrhythmias | Prevents sudden cardiac death | Not indicated for bradycardia/block | | **Permanent pacemaker** | Provides electrical pacing impulses | Treats symptomatic bradycardia/block | Restores adequate heart rate/rhythm | | Radiofrequency catheter ablation | Destroys arrhythmogenic tissue | Cures specific tachyarrhythmias | Not for conduction system failure | | Oral metoprolol | Beta-blocker, slows heart rate | Manages hypertension, angina | Worsens bradycardia, contraindicated | ### Detailed Breakdown The clinical presentation strongly suggests complete (third-degree) atrioventricular (AV) block. Progressive dyspnea, fatigue, and recurrent presyncope are classic symptoms of reduced cardiac output due to a slow heart rate (bradycardia). The physical examination findings are particularly pathognomonic: 1. **Variable intensity of the first heart sound (S1):** This occurs when there is AV dissociation. The PR interval varies, leading to the mitral and tricuspid valves closing at different stages of ventricular filling, resulting in variable force and intensity of S1. This is a hallmark of complete heart block. 2. **Prominent jugular venous pulse (JVP) with "cannon a" waves:** "Cannon a" waves are seen when the right atrium contracts against a closed tricuspid valve. This happens when the atrium contracts simultaneously with the ventricle (ventricular systole), which is characteristic of AV dissociation, commonly observed in complete heart block. Given this constellation of symptoms and signs, the patient has symptomatic complete AV block, which is a life-threatening condition requiring intervention. The definitive treatment for symptomatic complete AV block is a **permanent pacemaker**. A pacemaker delivers electrical impulses to the heart, ensuring a consistent heart rate and restoring AV synchrony (depending on the pacing mode), thereby alleviating symptoms and improving cardiac output. Let's consider why the other options are incorrect: * **Implantable cardioverter-defibrillator (ICD):** ICDs are used to treat life-threatening *tachyarrhythmias* (e.g., ventricular tachycardia, ventricular fibrillation) by delivering electrical shocks. They are not designed to treat bradycardia or AV block, although some ICDs have pacing capabilities, a pacemaker is the primary device for conduction disease. * **Radiofrequency catheter ablation:** This procedure is used to eliminate abnormal electrical pathways or foci that cause *tachyarrhythmias* (e.g., atrial fibrillation, supraventricular tachycardia, ventricular tachycardia). It is not indicated for the treatment of bradycardia or AV conduction block, which involves a failure of the heart's natural electrical conduction system. * **Oral metoprolol:** Metoprolol is a beta-blocker that slows heart rate and prolongs AV nodal conduction. Administering metoprolol to a patient with symptomatic bradycardia and complete AV block would further worsen their condition and is therefore contraindicated.
Related Clinical Topics
AIDS
AIDS (Acquired Immunodeficiency Syndrome) is the final, most severe stage of HIV infection, characterized by a profoundly compromised immune system that makes individuals highly susceptible to opportunistic infections and certain cancers. It is diagnosed when the CD4+ T-cell count drops below 200 cells/mm³ or when specific AIDS-defining opportunistic illnesses develop. The cornerstone of AIDS treatment is highly active antiretroviral therapy (HAART), a combination of drugs that suppress HIV replication, preserve immune function, and prevent further progression. HAART significantly reduces viral load, increases CD4+ T-cell counts, and improves overall health. Treatment also includes prophylactic antibiotics to prevent opportunistic infections and specific therapies for any active infections or cancers. Symptoms of AIDS are primarily due to the opportunistic infections and cancers that take advantage of the severely weakened immune system. Common manifestations include persistent fever, chronic diarrhea, significant unintentional weight loss, night sweats, fatigue, swollen lymph nodes, and recurrent severe infections like Pneumocystis pneumonia, Kaposi's sarcoma, and toxoplasmosis. Neurological complications such as AIDS dementia complex can also occur.
Chronic Hepatitis C Virus infection
Chronic Hepatitis C Virus (HCV) infection is a persistent inflammatory condition of the liver caused by the hepatitis C virus, defined by the presence of detectable HCV RNA for at least six months. This long-term infection can progressively lead to significant liver damage, including fibrosis, cirrhosis, and hepatocellular carcinoma. Current treatment primarily involves direct-acting antiviral (DAA) medications, which are highly effective oral regimens targeting specific viral proteins to inhibit HCV replication. These therapies typically achieve a sustained virologic response (SVR) in over 95% of patients, effectively curing the infection. Treatment duration usually ranges from 8 to 12 weeks, depending on the specific regimen and patient factors. Chronic HCV infection is often asymptomatic for many years, leading to a silent progression of liver disease. When symptoms do appear, they are often non-specific, such as fatigue, malaise, nausea, and right upper quadrant discomfort. As the disease advances to cirrhosis, signs of liver decompensation may emerge, including jaundice, ascites, peripheral edema, spider angiomata, and hepatic encephalopathy.
Chronic hypertension
Chronic hypertension is a persistent and sustained elevation of blood pressure, typically defined as a systolic blood pressure greater than or equal to 130 mmHg or a diastolic blood pressure greater than or equal to 80 mmHg on multiple occasions. It is a major modifiable risk factor for various cardiovascular diseases, stroke, and kidney disease. Treatment for chronic hypertension involves a multi-faceted approach, starting with lifestyle modifications such as dietary changes (e.g., DASH diet), regular physical activity, weight loss, and reduced sodium and alcohol intake. Pharmacological therapy is often necessary and may include various classes of antihypertensive medications like diuretics, ACE inhibitors, angiotensin receptor blockers (ARBs), beta-blockers, and calcium channel blockers, frequently used in combination to achieve target blood pressure. Chronic hypertension is often referred to as 'the silent killer' because it is frequently asymptomatic for many years, even at high levels. When symptoms do occur, they are typically non-specific and may include headaches, dizziness, nosebleeds, or shortness of breath, usually manifesting in severe or long-standing cases or during a hypertensive crisis. Most diagnoses are made during routine medical screenings.
SMLE Preparation Resources
Master the 2026 SMLE
Explore more clinical protocols in the SMLEREVISE Clinical Knowledge Library.
Try the QBank & Scaled Mocks